Summer is coming to an end and ragweed season is in full swing! This month’s Annals of Allergy, Asthma & Immunology is full of articles that will help you provide the best possible care for your patients. Have you wondered about the use of vaccines with patients on dupilumab? This month we have a review and expert panel report that provides impactful recommendations on this topic. In an interesting editorial, ACAAI President Dr. Gailen Marshall and President-elect Dr. James Tracy summarize this report and what is known about giving live vaccines to patients on biologics.
This month we introduce a new feature to Annals – our Distinguished Author program. Read more about the program in the editorial this month and a CME Review from our first Distinguished Author, Dr. Hugh Sampson. Dr. Sampson’s review explores the response to cutaneous allergen exposure in patients with eczema and fits with this month’s theme of atopic dermatitis and food allergy. Other reviews focus on how the gut microbiome impacts the risk of food allergy in childhood, understanding common therapeutic biologic targets present in atopic dermatitis and food allergy, and the use of oral food immunotherapy in patients with AD.
Asthma is well covered in this month’s original research articles. One study examines the contribution of caregiver and child anxiety to asthma quality of life and another looks at the adoption and implementation of single maintenance and reliever therapy in moderate-to-severe adult asthma. Another study examines the relationship between short acting bronchodilators and systemic corticosteroid use in the United States. Related to the theme of this month’s Annals, the development of a predictive model for atopic dermatitis is provided. Finally, there is a study looking at antibiotic allergy prevalence and documentation.
In an intriguing letter, read the story of how peanut oral immunotherapy may have protected an abducted child from severe illness. Other letters this month look at the accuracy of YouTube videos on food allergy, cannabis knowledge of allergists and their patients, the changes of IgE levels in patients with IgE deficiency, and caregiver perceptions on pediatric penicillin allergy delabeling.
The Marginal Zone explores the role of biofilms in chronic rhinosinusitis. Clearly a very sticky subject that will get you to chuckle!
This is far from an exhaustive list of content in September’s Annals. This month we have a letter commenting on a previous article – which serves as a reminder that if you have any comments Annals content, please consider sending us correspondence (email us at annals@ACAAI.org). We are always excited to hear how Annals has helped you improve the lives of your patients!
Mitchell H. Grayson, MD, FACAAI
Editor-in-Chief
